Using MIMIC™ Technology to Predict Human Immune Response

The MIMIC™ system provides the benefits of both standard 2D PBMC assays and animal models, while overcoming their drawbacks. MIMIC™ technology uses human PBMCs in engineered tissue constructs that are functionally equivalent to the human immune system. The MIMIC™ system is high-throughput and cost-effective, using industry-standard 96-well microliter plates on an automated platform. The MIMIC™ system is also modular, easily accommodating variations to address different applications (e.g., vaccine and adjuvant responses, autoimmune disease).

Comparison of MIMIC™ technology with existing methods. MIMIC™ better represents the human immune response.
Attributes Animal PBMC MIMIC™
Physiological environment yes no yes
Uses human cells no yes yes
Right vaccine introduction route yes no yes
High-throughput format no yes yes
Cost-effective no yes yes
Captures human diversity no yes yes